Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Idexx Laboratories Inc. buy The Goldman Sachs Group, Inc.

Start price
€473.70
17.01.24 / 50%
Target price
€598.91
17.01.25
Performance (%)
-1.48%
Price
€466.70
26.04.24
Summary
This prediction is currently active. With a performance of -1.48%, the BUY prediction by The_Goldman_Sachs_Gr is trending in the wrong direction. This prediction currently runs until 17.01.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this prediction

IDEXX Laboratories, Inc. (Symbol: IDXX) is a leading global developer, manufacturer, and distributor of veterinary diagnostic and information technology products and services, primarily catering to companion animal healthcare, livestock and poultry, water testing, and dairy. The company operates through various segments including Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry and Dairy, and Other Veterinary Businesses. Founded in 1983 and headquartered in Westbrook, Maine, IDEXX Labs continues to innovate and grow, driven by a strong commitment to scientific innovation, customer service, and overall animal health and well-being. With a wide range of diagnostic products, software solutions, and connected services, IDXX plays a significant role in the veterinary care industry and serves customers across more than 175 countries.

Performance without dividends (%)
Name 1w 1m
Idexx Laboratories Inc. 4.384% 4.384%
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by The_Goldman_Sachs_Gr for this prediction

In the thread Idexx Laboratories Inc. diskutieren
Prediction Buy
Perf. (%) -1.48%
Target price 598.910
Change
Ends at 17.01.25

IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $500.00 to $650.00. They now have a "buy" rating on the stock.
Ratings data for IDXX provided by MarketBeat

Stopped prediction by The_Goldman_Sachs_Gr for Idexx Laboratories Inc.

buy
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€404.20
03.11.23
€466.10
03.11.24
15.46%
26.04.24